Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.73 |
| ▸ | CA6 | P23280 | 5/20 | 0.73 |
| ▸ | CA7 | P43166 | 5/20 | 0.73 |
| ▸ | CA9 | Q16790 | 5/20 | 0.73 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.73 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.73 |
| ▸ | CA2 | P00918 | 4/20 | 0.73 |
| ▸ | CA4 | P22748 | 4/20 | 0.73 |
| ▸ | CA5A | P35218 | 4/20 | 0.73 |
| ▸ | LMNA | P02545 | 3/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.73 |
| ▸ | CA3 | P07451 | 3/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.73 |
| ▸ | CA1 | P00915 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL902205 | 1.00 | — | — | |
| SCHEMBL11199787 | 1.00 | CA12 (0.73) | CA12CA6CA7CA9CA14 | |
| SCHEMBL2538760 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL3840289 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL181401 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL25342018 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL581603 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL25342922 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL15439 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL25340653 | 0.86 | CA12 (1.00) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114100382-B | Modified PVDF (polyvinylidene fluoride) film with demulsification performance and preparation method thereof | 上海应用技术大学 | 2024-06-28 | — | — | CN | claimed |
| WO-2019227559-A1 | SOLID CONDUCTIVE GEL SUITABLE FOR ELECTROCHEMICAL SYSTEM AND PREPARATION METHOD THEREFOR | 江苏大学 (CN) | 2019-12-05 | — | — | WO | claimed |
| CN-117603250-A | Method for preparing isocyanate from polycarbonate | 诠达化学股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-114206967-B | Organic-inorganic hybrid material, preparation method thereof and preparation method of initial raw material thereof | 诠达化学股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-109890814-B | Compounds comprising benzo [ D ] [1,3] oxathiolane 3-oxides and methods/uses thereof | 普拉马纳制药公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-110582526-B | Epoxy resin composition containing sulfanilamide | 陶氏环球技术有限责任公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-109641854-B | Modulators of integrated stress pathways | 卡里科生命科学有限责任公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-114100382-A | Modified PVDF (polyvinylidene fluoride) membrane with demulsification performance and preparation method thereof | 上海应用技术大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-112135812-B | Ketamine derivatives and pharmaceutical compositions thereof | 凯瑞康宁生物工程（武汉）有限公司 | 2022-01-18 | — | — | CN | disclosed |
| CN-113164776-A | Tyrosine kinase inhibitor compositions, methods of making and methods of using the same | 黑钻治疗公司 | 2021-07-23 | — | — | CN | disclosed |
| US-20210121411-A1 | LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERY OF MRNA AND LONG NUCLEIC ACIDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-04-29 | — | — | US | disclosed |
| US-5431962-A | Abrasion resistant floor covering | CHEMPROOF POLYMERS, INC. (US) | 1995-07-11 | — | — | US | disclosed |
| WO-1994024237-A1 | A METHOD OF REDUCING SLUDGE AND VARNISH PRECURSORS IN LUBRICATING OILS | EXXON CHEMICAL PATENTS INC. (US) | 1994-10-27 | — | — | WO | disclosed |
| US-5143999-A | For sealing, adhesives, molding resins, casting resins or coating compositions | CIBA-GEIGY CORPORATION (US) | 1992-09-01 | — | — | US | disclosed |
| WO-1992010285-A1 | MICROCAPSULE HAVING TEMPERATURE-DEPENDENT PERMEABILITY PROFILE | LANDEC LABS, INC. (US) | 1992-06-25 | — | — | WO | disclosed |
| CN-1056681-A | Selectivity prepares straight chain Triethylenetetramine (TETA) and N-aminoethyl ethanolamine | UNION CARBIDE CHEM PLASTIC (US) | 1991-12-04 | — | — | CN | disclosed |
| US-4859245-A | REACTION PRODUCT OF TALL OIL DERIVATIVE AND AMINO COMPOUND | WESTVACO CORPORATION (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0252997-A1 | PROCESS FOR FORMING COLORED IMAGE | FUJI PHOTO FILM CO., LTD. (JP) | 1988-01-20 | — | — | EP | disclosed |
| US-4175069-A | Plasticization of neutralized sulfonated elastomeric polymer | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-11-20 | — | — | US | disclosed |
| US-3975350-A | HYDROPHILIC OR HYDROGEL CARRIER SYSTEMS SUCH AS COATINGS, BODY IMPLANTS AND TOHER ARTICLES | PRINCETON POLYMER LABORATORIES, INCORPORATED (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210121411-A1 | LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERY OF MRNA AND LONG NUCLEIC ACIDS | NSUN3, ABHD16A, SARNP | CA12 2783/4885CA6 2851/4885CA7 4192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.